Praxis Precision Medicines, Inc. (PRAX) — Stock Score Summary

Praxis Precision Medicines, Inc. (PRAX) has a MoatMap StockRank of 71/100 based on Quality (41/100), Value (36/100), and Momentum (74/100) factor scores. The current signal is BUY.

Praxis Precision Medicines, Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies for central nervous system (CNS) disorders. Its drug pipeline targets conditions such as epilepsy, movement disorders, and depression by addressing neuronal excitation-inhibition imbalance. The company distinguishes itself through a precision medicine approach, aiming to provide targeted treatments for patients with high unmet medical needs.

Key Financial Metrics

Price$342.58
Market Cap$9.2B
P/E (Forward)-33.63
Price/Book9.52
Return on Equity-35.3%
Return on Invested Capital-37.1%
Debt/Equity0.10
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-176M

Praxis Precision Medicines, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Praxis Precision Medicines, Inc.’s (PRAX) StockRank?
MoatMap’s StockRank for Praxis Precision Medicines, Inc. (PRAX) is 71/100, with a Buy signal. It is a composite of Quality (41), Value (36), and Momentum (74) factor ranks across MoatMap’s 15,000+ stock universe.
Does Praxis Precision Medicines, Inc. have an economic moat?
Praxis Precision Medicines, Inc. (PRAX) has a Quality factor score of 41/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Praxis Precision Medicines, Inc. a buy, hold, or sell?
MoatMap’s current signal for Praxis Precision Medicines, Inc. (PRAX) is Buy, based on a StockRank of 71/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Praxis Precision Medicines, Inc. in?
Praxis Precision Medicines, Inc. (PRAX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksPRAX deep dive reportAI ChampionsHow we score stocksSense-check another stock